CAMERON SMITH: Open Payments
NPI 1821525692 · BELHAVEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 7 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $63 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Purdue Pharma L.P. | 1 | $22 |
| bioMerieux Inc | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
Products named: TRELEGY ELLIPTA, GVOKE HYPOPEN, NALMEFENE HYDROCHLORIDE, BIOFIRE SPOTFIRE Control Station, Korlym, Ozempic.
Industry payments across NC — which companies pay providers there.
